To the Editor: In Australia, when melatonin is requested in doses higher than those available in preprepared formulations, in different dosage forms, or for people under 55 years of age, private prescriptions and extempora-neous preparations are often used. There is evidence of efficacy of melatonin in shiftwork-related sleep disorders, jet lag, circadian rhythm disorders, and for older people with chronic insomnia, but not for insomnia generally.1-3 There is concern over increasing use of melatonin in children, but no current data exist for actual melatonin usage patterns in Australia. In September 2010, we conducted a 2-week prospective drug use audit of melatonin prescriptions dispensed to patients by Australian compounding pharmacies.
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
- 1. Stampfer HG, Hood SD. Circadian rhythms: keeping pace with developments. Med J Aust 2009; 191: 479-480. <MJA full text>
- 2. Wade A, Downie S. Prolonged-release melatonin for the treatment of insomnia in patients over 55 years. Expert Opin Investig Drugs 2008; 17: 1567-1572.
- 3. National Prescribing Service. Melatonin prolonged-release tablets (Circadin) for primary insomnia in older people. Sydney: NPS RADAR, 2010. http://www.nps.org.au/health_professionals/publications/nps_radar/2010/may_2010/melatonin (accessed Mar 2012).
- 4. Tze-Min Ang K, Saini B, Wong K. Sleep health awareness in pharmacy undergraduates and practising community pharmacists. J Clin Pharm Ther 2008; 33: 641-652.
- 5. Giam JA, McLachlan AJ, Krass I. Specialized compounding in community pharmacies: organizational perspective. J Am Pharm Assoc (2003) 2010; 50: 354-361.
No relevant disclosures.